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Fat-associated lymphoid clusters (FALCs) are atypical lymphoid tissues that were 
originally identified in mouse and human mesenteries due to that they contain a high 
number of type 2 innate lymphoid cells/nuocytes/natural helper cells. FALCs are located 
on adipose tissues in mucosal surfaces such as the mediastinum, pericardium, and 
gonadal fat. Importantly, these clusters contain B1, B2 and T lymphocytes as well as 
myeloid and other innate immune cell populations. The developmental cues of FALC 
formation have started to emerge, showing that these clusters depend on a different set 
of molecules and cells than secondary lymphoid tissues for their formation. Here, we 
review the current knowledge on FALC formation, and we compare FALCs and omental 
milky spots and their responses to inflammation.
Keywords: lymphoid tissues, fat-associated lymphoid clusters, peritoneal inflammation, peritoneal immune 
responses, tertiary lymphoid structures
inTRODUCTiOn
The interactions between different types of immune cells are essential for both innate and adaptive 
immune responses to pathogens. Such interactions require strategically situated microenvironments 
to increase the chances that rare antigen-specific lymphocytes become activated. These specialized 
microenvironments are found in secondary lymphoid organs (SLOs) such as lymph nodes and 
Peyer’s patches. Specialized populations of CD45− fibroblastic and endothelial cells express an 
arrangement of cell adhesion molecules, chemokines, and survival factors that guide the recruit-
ment, co-localization and interactions of bone marrow-derived cells to their specific areas being 
T cells and dendritic cells (DCs) to the T cell area while B cells and follicular T helper cells to the B cell 
follicles. The development and organization of secondary lymphoid tissues is dependent on signals 
by the tumor necrosis factor (TNF) family of proteins such as lymphotoxin αβ (LTαβ), lymphotoxin 
β receptor (LTβR), and TNF-TNF receptor I and the downstream pathways such as activation of the 
nuclear factor kappa B family of transcription factors. The target genes of these pathways include 
the cell adhesion molecules VCAM-1, ICAM-1, MAdCAM-1, and the chemokines CXCL13, CCL19, 
and CCL21. Several detailed reviews of the processes that mediate lymph node development have 
been published (1–3).
Lymph nodes are characterized by well-defined B and T cell areas. B cell areas contain follicles 
that are organized by a specific population of reticular cell expressing the B cell-attracting chemokine 
TABLe 1 | Main characteristics of mucosal lymphoid tissues.
Lymphoid 
structure
Location Structural organization Ontogeny Developmental requirements Reference
Bronchial-
associated 
lymphoid tissue 
(BALT)
Near the basal side 
of the bronchial 
epithelium of the 
lungs
Arranged in a B cell follicle 
with clusters of IgD+ cells, 
grouped around follicular 
dendritic cells (FDCs). They 
also contain a discrete T 
cell zone
Formation after birth, 
following antigen exposure or 
inflammatory challenge. High 
frequency in the neonatal  
stage
Defective architecture in Lta−/− 
mice. Defective number in Il7ra−/− 
mice. Absent in mice lacking 
Cxcl13, Ccl19, and Ccl21a
Fleige et al. (5), Kocks 
et al. (8), Moyron-Quiroz 
et al. (20), Rangel-
Moreno et al. (9)
Isolated lymphoid 
follicles
Along the anti-
mesenteric wall of 
the small intestine
Composed of a B cell area 
(germinal center) and few 
T cells
Formation after birth in 
response to inflammation or 
infection
Absent in Lta−/−, Ltbr−/− Aly/aly,  
Cxcr5−/−, and Rorc−/− mice. 
Requirement of commensal flora 
for maturation
Baptista et al. (10), 
Hamada et al. (11), 
Lorenz et al. (12), 
Velaga et al. (21)
Nasopharyngeal-
associated 
lymphoid tissue 
(NALT)
Nasal passages of 
the nasal cavity
Composed of B and T cell 
areas
Formation after birth, first 
detected at postnatal day 7 in 
mouse
Defective formation in Lta−/−, 
Ltbr−/−, Il7ra−/−, Aly/aly, Cxcr5−/−, 
and Cxcl13−/− mice. Absent 
in Id2−/− mice. Requirement of 
microbiota for maturation
Asanuma et al. (15), 
Fukuyama et al. (16), 
Harmsen et al. (22), 
Rangel-Moreno et al. 
(23)
Tear duct-
associated 
lymphoid tissue 
(TALT)
Lacrimal sac and 
tear duct of the eye
Composed of B cell 
aggregates, DCs and T cells
Formation after birth, between 
postnatal days 5 and 10 in 
mouse
Defective size and number in 
Lta−/−, Il7ra−/−, and Cxcl13−/− mice. 
TALT formation is preserved in 
Id2−/− and Rorc−/− mice
Nagatake et al. (13), 
Paulsen et al. (14)
Portal tract-
associated 
lymphoid tissue
Portal triad of the 
liver
Composed of B cell 
aggregates, FDCs and T 
cells
Formation after birth, triggered 
in response to bacterial and 
viral infections
Formation may be dependent on 
CCL21 expression
Grant et al. (17), 
Yoneyama et al. (18)
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CXCL13. Paracortical T cell areas are organized by a different 
type of stromal cells named T zone reticular cells that express 
CCL21 and CCL19, which attract T cells, and DCs to facilitate 
their interactions (4).
In addition to secondary lymphoid tissues such as lymph 
nodes, there are a series of inducible lymphoid tissues present 
in mucosal surfaces such as bronchial-associated lymphoid tis-
sues (BALT) in the lung (5–9), gut-associated lymphoid tissues 
that comprise the isolated lymphoid follicles in the intestine 
(ILFs) (10–12), tear duct-associated lymphoid tissues (13, 14), 
nasopharyngeal-associated lymphoid tissues (NALT) (15, 16) 
and portal tract-associated lymphoid tissues (17, 18) to cite a few 
examples (see Table 1). Recently a novel type of lymphoid tissue 
called fat-associated lymphoid clusters (FALCs) has been identi-
fied in the mesenteries of humans and mice (19).
THe STRUCTURe OF FALCs
Fat-associated lymphoid clusters are non-classical lymphoid 
tissues associated to adipocytes in mucosal surfaces, including 
omental, mesenteric, mediastinal, gonadal, and pericardial fat 
(19, 24, 25).
The frequency of FALCs varies among different adipose tissues 
(AT) in mice. Whereas gonadal AT has as little as 1–2 clusters, the 
omentum can harbor up to 80 clusters per depot in homeostatic 
conditions (24). This heterogeneity is also reflected in FALC size, 
which ranges from 100 to 500 µm in diameter (19).
Unlike lymph nodes, FALCs are not encapsulated and are in 
direct contact with surrounding adipocytes (19). The arrangement 
of leukocytes found in FALCs also differs from the organization 
of conventional SLOs. For instance, no discernible B and T cell 
compartmentalization areas are evident. Instead, FALCs from 
mesenteric AT are composed of a tight cluster of B220+ or IgM+ B 
cells, with variable numbers of CD4+ T cells and CD11b+ myeloid 
cells (19, 24). Both myeloid cell precursors (CD31/ER-MP58+) 
and mature macrophages (F4/80+) have been detected in omental 
FALCs, suggesting that these lymphoid clusters form permis-
sive microenvironments where the former cells can proliferate 
locally to be a source of free macrophages within the peritoneal 
cavity (32). A similar process is likely to take place in FALCs in 
the mediastinum and pericardium (33, 34). Importantly, FALCs 
contain type 2 innate lymphoid cells (ILC2) that can support the 
proliferation of B1 cells through the expression of IL-5 (19).
B cell recruitment to mesenteric FALCs requires the presence 
of a network of stromal cells expressing the chemokine CXCL13 
(24). These cells are found scattered along the lymphoid clusters 
and are thought to be different from follicular dendritic cells 
(FDCs), which require signaling through LTβR to induce CXCL13 
expression (35). Importantly, FALCs are present in Cxcl13−/− mice 
although they are devoid of B cells and their size is smaller than 
in their wild type littermates.
Fat-associated lymphoid clusters are highly vascularized 
as shown by their close association to blood vessels (19, 24). 
Moreover, lymphoid clusters in the omentum have also been 
found to contain high endothelial venules (HEVs), a specialized 
type of post-capillary venules essential for lymphocyte trafficking 
(30, 36). In contrast, FALCs connection with lymphatic vessels 
remains to be further investigated (24, 25, 27, 37). Earlier evidence 
has shown that FALCs in the omentum can collect antigens and 
particles directly from fluids within the peritoneal cavity (27).
FiGURe 1 | Model of fat associated lymphoid cluster (FALC) formation. In homeostasis, FALC formation can be modulated by different signals, including 
colonization by commensal microbiota, tumor necrosis factor (TNF) signaling, and type 2 innate lymphoid cells function. These signals may trigger cytokine 
production from local cells within the adipose tissue. For instance, CXCL13-expressing stromal cells can promote the recruitment of B cells into arranged lymphoid 
clusters. Following an inflammatory challenge, FALCs increase in number and size. Under these conditions, infiltrating macrophages are able to secrete TNF, which 
upon signaling through TNF receptors in stromal cells, promoting FALC growth. Moreover, invariant natural killer T cells stimulate FALC formation through the 
production of T helper type 2 cytokines, including IL-4 and IL-13, which may also promote the resolution of inflammation.
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DeveLOPMenTAL ReQUiReMenTS FOR 
FALC FORMATiOn
Conventional SLOs such as lymph nodes and Peyer’s patches 
develop in a timely manner during embryogenesis, independently 
of pathogen-induced inflammation (38). In contrast, FALCs 
develop postnatally and could be identified at around 2–3 weeks 
after birth, reaching a plateau at around 18 weeks of age in mice 
(24). Unlike classical SLOs, FALC formation is not dependent on 
LTβR signaling as shown by the occurrence of these clusters in 
Ltβr−/− and Ltα−/− mice (24). Furthermore, FALCs also form in 
Rag2−/− and Rorc−/− mice, which lack B and T cells and LTi/ILC3 
cells, respectively. FALCs are not the only lymphoid structures 
that develop independently of LTi cells and LTβR signaling, as 
other mucosal-associated lymphoid tissues, but also follow these 
developmental requirements (see Table 1) (9, 13, 16, 39).
Fat-associated lymphoid clusters are absent in Rag2−/−Il2rg−/− 
mice, which lack lymphocytes and ILCs, indicating a require-
ment of the latter for their development (24). Moreover, FALC 
formation is defective in Tnfrsf1a−/−Tnfrsf1b−/− mice, which lack 
TNF receptors (TNFR1 and TNFR2) (24). Further analysis has 
shown that AT macrophages are the main source of TNF and that 
stromal cells respond to this cytokine via TNFR, leading to FALC 
formation (Figure 1) (24).
Fat-associated lymphoid cluster numbers are also greatly 
reduced in germ-free (GF) mice, suggesting a potential role 
of commensal flora in the formation of these structures (24). 
Interestingly, other lymphoid structures such as ILFs, which are 
found in the wall of the small intestine, are reduced or immature 
in GF mice (10). This suggests that similar to ILFs, the presence 
of commensal microbes or their by-products results in an inflam-
matory stimulus that induces the formation of FALCs. It will be 
interesting to test whether disruption of the intestinal epithelial 
barrier has an effect in the number and/or cellular composition 
of mesenteric FALCs (29).
ARe FALCs SiMiLAR TO MiLKY SPOTS 
(MS) OF THe OMenTUM?
Milky spots were first described by von Recklinghausen in 1863 
as white spots in the omentum of rabbits (40). These structures 
were later characterized as highly vascularized accumulations 
of macrophages, B and T lymphocytes, and mast cells within 
the stroma of the greater omentum (41, 42). The omentum is 
generally divided in two parts, the greater and lesser omentum, 
depending on its position within the peritoneal cavity. Moreover, 
the omentum contains two distinguishable regions: a translucent 
collagenous membrane-like region and an adipose-rich region 
TABLe 2 | Comparison of milky spots (MS) and fat-associated lymphoid clusters (FALCs).
Feature MS FALCs
Location Greater omentum Mesenteric, mediastinal gonadal, and pericardial fat (19, 24, 25)
Size 349–756 µm in diameter in humans (26). 850 µm in diameter in  
healthy rabbits (27)
100–500 µm in diameter in mice (19). Size tends to increase with 
age (28)
Cell composition Macrophages (47.5%) B lymphocytes
B lymphocytes (29.1%) T lymphocytes
T lymphocytes (11.7%) Macrophages
Mast cells (6.1%) (26)
Type 2 innate lymphoid cells (ILC2) (19) ILC2 (20–40%) (19)
CXCL13+ and FDCM1+ stromal cells (29, 30) CXCL13+ stromal cells (24)
Developmental 
requirements
MS develop independently of ILC3/LTi cells and the chemokines  
CCL19 and CCL21. On the other hand, MS are defective or  
absent in Cxcl13−/− and Ltα−/− mice (30)
FALCs develop independently of ILC3/LTi cells and LTβR 
signaling. In contrast, their development is dependent on TNF 
signaling on stromal cells. IL-4R signaling and the presence of 
invariant natural killer T cells are also required. The requirement for 
type 2 ILCs in FALC development remains to be investigated (24)
Ontogeny Accumulation of myeloid cells in the greater omentum has been  
observed at 20 weeks of gestation. True MS are observed at  
35 weeks of gestation in humans (31)
Mesenteric FALCs are formed after birth, with visible clusters at 
2–3 weeks of age in mice (24)
4
Cruz-Migoni and Caamaño Fat-Associated Lymphoid Clusters
Frontiers in Immunology | www.frontiersin.org December 2016 | Volume 7 | Article 612
containing blood and lymphatic vessels, stromal cells, and clus-
ters of immune cells (43). In mice and humans, MS have been 
found in the adipose region of the omentum, whereas in dogs, 
the aggregates of lymphoid cells are only found scattered in the 
translucent area (43, 44). However, no clear distinction in the 
exact location of MS within the omentum has been established. 
Interestingly, some authors have divided MS in two categories: 
vascularized and non-vascularized MS. Vascularized MS are sup-
plied with blood vessels and are found in the omental fat region. 
On the other hand, non-vascularized MS do not have blood 
supply and are located in the omental membrane (45). Whether 
these features that translate into functional differences remain to 
be investigated.
A close examination showed no discernible differences 
between MS and the FALCs in mesenteries, mediastinum, and 
gonadal fat (see Table 2). In light of their similar characteristics 
but distinct locations and for clarity, we will be calling the omental 
MS as omFALCs while mesFALCs correspond to the clusters in 
the mesenteries, medFALCs the structures in the mediastinum, 
perFALC for the structures in the pericardium, and gonFALC the 
clusters present in gonadal fat.
FALC ReSPOnD TO inFLAMMATiOn AnD 
iMMUniZATiOn
MesFALCs and omFALCs increase in number and size in response 
to acute or chronic peritoneal inflammation (24, 27, 37). For 
instance, upon intraperitoneal (IP) injection of Zymosan, a yeast-
derived ligand of Toll-like receptor 2, the abundance and size of 
mesFALCs increased significantly (24). Rag2−/− and Cd1d−/− mice 
failed to induce FALC formation in response to Zymosan-induced 
inflammation. Interestingly, IP injection of invariant natural killer 
T (iNKT) cells into Rag2−/− mice was able to restore mesFALC 
formation following Zymosan challenge, indicating a role of 
iNKT cells in this process (24). More specifically, activated iNKT 
cells can produce T helper type 2 (TH2) cytokines, including IL-4 
and IL-13, which may have redundant roles in the formation of 
FALCs following peritoneal inflammation in the BALB/c strain 
background (Figure 1) (24).
Likewise, IP injection of lipid A, a component of bacterial 
lipopolysaccharide, leads to an increase in the number of B1 cells 
and macrophages in the omentum (29). Moreover, IP injection 
of polydextran particles or polyacrylamide beads increases the 
number and size of omFALC (37, 46). Different models of inflam-
mation including TNF injection, Escherichia coli infection, and 
cecal ligation lead to the influx of neutrophils to the omFALC 
via HEVs (36).
Earlier evidence of the mechanisms by which FALCs respond 
to immunization comes from studies on immune responses in 
the omentum. Using an elegant mouse model that lacks spleen, 
lymph nodes, and Peyer’s patches (SLP mice), Rangel-Moreno, 
Randall, and colleagues have shown that omFALC are sufficient 
to respond to an immunological challenge and support T cell 
responses, immunoglobulin switching, and moderate affinity 
maturation (30). It is possible that the antigen-specific immune 
response shown in serum in SLP mice upon IP immunization 
that had been attributed to the omFALC may have a relative con-
tribution from mesFALCs. Peritoneal immunization resulted in 
a marked recruitment of macrophages to the omFALC similar to 
what has been shown in mesFALCs (24). OmFALCs were shown 
to collect IP injected fluorophore-labeled antigens or GFP-labeled 
tumor cells. Peritoneal cell migration to the omentum is medi-
ated by mechanisms that are both dependent and independent of 
chemokines, but clustering of B and T lymphocytes is dependent 
on the latter.
Macrophages are the most important cell type to engulf and 
eliminate bacteria in omFALCs (30). Indeed, it has been shown 
in a diet-induced obesity model that macrophages in gonFALC 
are able to proteolytically process antigen and present it in the 
5Cruz-Migoni and Caamaño Fat-Associated Lymphoid Clusters
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context of MHC II complexes, indicating that they can function 
as antigen-presenting cells to induce T cell proliferation (47). 
Furthermore, IP immunizations with T-cell-dependent antigens 
showed that antigen-specific B cells undergo expansion, Ig 
switching, and acquired markers of GC reaction further indicat-
ing that adaptive immune responses take place in mesFALCs (24).
Mesenteric FALCs are also able to respond to intestinal 
helminth infection (Nippostrongylus brasiliensis) via ILC2 
activation and expression of the TH2 cytokines IL-5 and IL-13. 
These cytokines are produced in response to IL-33 and IL-25 and 
promote goblet cell hyperplasia and helminth expulsion (19, 48). 
Likewise, a recent report has shown that medFALCs and perFALCs 
respond to both lung infection with the nematode Litomosoides 
sigmodontis and lung inflammation via fungal allergen inhalation 
(33). Under these conditions, medFALC stromal cells produce 
IL-33, which leads to ILC2 activation and IL-5 secretion. This 
in turn promotes the recruitment and activation of B cells and 
culminates in the production of natural IgM antibodies (Ab) for 
local protection (33).
A recent report has shown that medFALC are present in large 
numbers in two animal models of autoimmunity that develop 
a phenotype similar to human systemic lupus erythematosus 
(SLE) (49). The MRL/MpJ-lpr mouse model carries a mutation 
in the gene encoding Fas, a cell membrane receptor that induces 
caspase activation and apoptosis. This mutant strain develops a 
severe autoimmune syndrome with lymphadenopathy, spleno-
megaly, and the production of anti-double strand DNA (dsDNA) 
Ab as well as immune complex deposition in several organs 
including kidney, resembling human SLE. The BXSB/MpJ-Yaa 
mice developed systemic autoimmunity, with males being more 
affected due to a locus called autoimmune accelerator located in 
the Y chromosome. Both strains showed large medFALCs size 
that correlated with a significant increased level of immune cell 
infiltration in the lungs with respect to their control strains (49). 
It will be interesting to assess whether medFALCs in the MRL/
MpJ-lpr model contained anti dsDNA Ab-forming B cells.
Several reports indicate a link between FALCs and cancer 
metastasis in the peritoneum. A study has shown a direct cor-
relation between the presence and number of FALCs and the 
colonization of the clusters by ovarian cancer cells, with the 
omentum containing the largest number of FALCs and metasta-
sis/foci of tumor cells (50). The foci formation by tumor cells in 
FALCs is not affected by the absence of lymphocytes, indicating a 
role for specialized stromal cells, endothelium, and adipocytes in 
the clusters that facilitate malignant cell recruitment. Similarly, IP 
injection of gastric and colon cancer cells resulted in their rapid 
migration and survival in omental and mesFALCs (51–53). These 
reports together with the evidence of metastasis formation in the 
omentum and peritoneal cavity for some human cancers (54) 
indicate the presence of a favorable microenvironment in FALCs 
that allows the tumor cells to thrive and form micrometastasis 
in these tissues. Along this line, some reports have shown that 
gastric, colon, and some liver cancer cells express the chemokine 
receptors CCR4 and CXCR4, whereas cell populations from 
omFALCs and mesenteries can express their ligands (CCL22 and 
CXCL12), which may favor their migration to these structures 
(51, 52, 55).
COnCLUSiOn
The rapid formation of FALCs following inflammation or infec-
tion, the changes in cellular composition and the presence of 
innate immune cells and B cells undergoing a germinal center 
reaction indicate a central role for these clusters in the formation 
of local immune responses.
Understanding what signals and cells are essential to FALC 
formation in homeostasis and following infection will allow 
inducing their formation to support antitumor responses. 
Conversely, it may be possible to reduce or preclude FALC 
formation during aberrant immune responses or peritoneal 
inflammation.
The physiological significance of the close association of 
FALCs with visceral AT remains to be further investigated. It is 
tempting to hypothesize that FALCs have an additional function 
in supporting type 2 ILCs and other immune cells that ultimately 
maintain the homeostasis of AT and whole body metabolism. 
Ultimately, understanding FALC formation in the mesenteries, 
omentum, and gonadal fat may facilitate the design of therapies 
to target low-grade chronic inflammation and other symptoms 
associated with obesity and metabolic syndrome.
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